Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Survey Highlights High Prevalence of Social Determinant Challenges, Need to Better Address Them
The 2018 Consumer Perspectives on How Social Determinants Impact Clinical Experience report found that 68% of Americans have at least 1 social determinant challenge and the majority do not discuss their challenges with their provider or insurance company.
CDC Launching Surveillance System to Study Multiple Sclerosis, Other Neurological Conditions
With $5 million appropriated from Congress, CDC is launching a National Neurological Conditions and Surveillance System to help increase understanding of neurological disorders and to further support neurologic research, starting with multiple sclerosis and Parkinson disease.
NIH Announces Funding for HIV Treatment, Prevention Research in Vulnerable Southern Counties
The National Institutes of Health (NIH) said that it will fund a series of collaborations with medical research institutions in the region as part of a new initiative that will expand ongoing research at the NIH-funded Centers for AIDS Research, a group of HIV-focused research institutions focused on reducing the burden of HIV domestically and globally.
Myelofibrosis Survival After Discontinuing Ruxolitinib Differs Based on Reason for Discontinuation
Following failure with ruxolitinib, there are limited treatment options available and among these patients who fail on the treatment, prognosis is unfavorable, particularly among those who started ruxolitinib with advanced stage disease, according to a study presented at the 60th American Society of Hematology Annual Meeting & Exposition.
Ruxolitinib Results in Better Treatment Response, Less Toxicity in Early Primary Myelofibrosis
According to a study presented at the 60th American Society of Hematology Annual Meeting & Exposition, held December 1-4 in San Diego, California, a World Health Organization–defined diagnosis of primary myelofibrosis may help better identify patients who may need strict monitoring during treatment with ruxolitinib.
Migraine With Aura Associated With Increased Risk of Atrial Fibrillation
New research finds migraine with aura is associated with an increased risk of atrial fibrillation (AF), which may help provide a clearer picture of the relationship between the migraine subtype and cardioembolic stroke, as AF is a common source of cardioembolic stroke.
Telemedicine Use Among Physicians Remains Relatively Low
In 2016, 15.4% of physicians worked in practices that used telemedicine for a wide spectrum of patient interactions, including e-visits, and 11.2% of physicians worked in practices that used telemedicine for interactions between physicians and healthcare professionals.
Research to Look Out for at ASH 2018
From December 1-4, hematology professionals from across the globe will convene in San Diego, California for the American Society of Hematology annual meeting to present and discuss their research and latest developments in malignant and non-malignant hematology. Here’s what to look out for during the meeting.
Engaging Employees in Health Benefit Design Increases Satisfaction With Coverage Options
During a case study, employees were more willing to have less robust coverage in areas like dental, vision, and diagnostic benefits so that the group could have access to more comprehensive mental health and maternity services.
Cellular Proliferation Drives HIV Persistence During Treatment With ART
According to a new study, cellular proliferation generates the majority of infected cells during antiretroviral therapy (ART), suggesting that reducing proliferation can decrease the size of the HIV reservoir and work toward a cure.
Assessment Can Help ED Physicians Predict Poor Prognosis for Patients With Febrile Neutropenia
The quick sequential (sepsis-related) organ failure assessment can help emergency department physicians identify which patients with neutropenia are at risk of a poor prognosis and should receive prompt empirical antimicrobial therapy, according to a new study.
Report Finds Wide Variation in Average Cost of Healthcare Across the US
A report assessing healthcare utilization and cost patterns in 6 regions across the United States highlighted stark differences in average healthcare costs, with Maryland falling 20% below the average and Colorado landing 19% above average.
Study Identifies High Burden of Invasive Infections in Neutropenic Patients
One-third of neutropenic patients developed invasive infection following intensive chemotherapy, which was significantly associated with an increase in mortality up to 100 days after the start of neutropenia.
Provider Stigma Toward HIV Slows Prevention Goals
As physicians have an essential role in the fight against HIV—leading patients through the care continuum—understanding HIV-related stigma among physicians can inform development of interventions to reduce this stigma and promote positive clinical outcomes.
Cancer Surpasses CVD as Leading Cause of Death in High-Income Counties
As a result of increased prevention and improved medical treatment of cardiovascular disease (CVD), and despite increasing rates of obesity and diabetes, cancer has gradually surpassed CVD as the leading cause of death in high-income counties. However, CVD is more likely to be the leading cause of death in low-income counties.
27% of Families Delay Medical Care Due to Costs
A survey of nearly 700 people, each with at least $35,000 in household income, found that more than half of respondents are concerned about their ability to pay a medical bill of less than $1000, with 35% being concerned about paying a medical bill under $500.
Antiviral Therapy Prevents HCV in Patients Receiving Infected Donor Hearts
Preliminary data from a new study has demonstrated that pre-emptive administration of pan-genotypic, direct-acting antiviral therapy prevents hepatitis C virus (HCV) infection in HCV-negative cardiac transplant patients receiving donor hearts infected with the virus.